Stanford University
Showing 21-30 of 665 Results
-
Frank Abild-Pedersen
Senior Scientist, SLAC National Accelerator Laboratory
BioDr. Abild-Pedersen is the co-director of SUNCAT Center for Interface Science and Catalysis. He is leading a research team that focuses on developing an understanding of the factors determining the catalytic properties at the interface between gas/solvent and solid surfaces and to apply these insights to processes and catalysts of importance for energy transformations and for sustainable chemical production. His research takes advantage of computer facilities at SLAC and Stanford to gain the necessary understanding and to link these simulations to experiments where new catalyst synthesis methods are developed, and the catalyst materials are characterized both in terms of performance (activity, selectivity, durability, etc.) and in terms of geometrical and electronic structure. The underlying philosophy of his research is that by having a fundamental understanding of the way surfaces catalyze a chemical reaction we can make a quantum leap in our ability to make predictions for new catalysts and processes. This requires the development of a theory of heterogeneous catalysis, including electrocatalysis, based on computational and experimental results.
Dr Abild-Pedersen has extensive experience with simulations and modeling of chemical reactions. His work began with the derivation of energy correlations in catalysis that have helped speed up screening for active, selective and stable catalysts for energy conversion as a graduate student working with Professor Jens K. Nørskov at the Technical University of Denmark. He moved to SLAC in 2010 as a staff scientist and helped build up SUNCAT and define research directions in the field of heterogeneous catalysis. -
Oscar J. Abilez
Senior Scientist, Cardiothoracic Surgery - Pediatric Cardiac Surgery
Current Research and Scholarly InterestsDr. Abilez' interests are aimed at elucidating how various biophysical and biochemical perturbations regulate early cardiovascular development across time and length scales that span several orders of magnitude, using human pluripotent stem cells as a model system.
